The Use of Procalcitonin as a Diagnostic Marker in Infectious Diseases

David N. Gilbert, MD, MACP
Thursday, February 24, 2022
Category: Bacterial Infections, COVID-19, Diagnostics, Hospital Infections

Dr. David Gilbert, Professor of Medicine at Oregon Health Sciences University, presents an update on the use of procalcitonin as a diagnostic marker. Dr. Gilbert emphasizes the role of procalcitonin in three main clinical sydromes: Community acquired pneumonia, Sepsis, and COVID-19 Pneumonia.

Stay in touch! Download our app in the iTunes store or the Google Marketplace.